A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
September 19, 2011
Faculty are encouraged to apply for the T1 Translational Catalyst Award, which is designed to help drive promising, early-stage research through the lengthy and complex process of bringing products and procedures to patients.
October 04, 2010
Synuclein is a protein that can cause Parkinson’s disease, although it is not clear how. UCSF researcher Robert Edwards, MD, now has discovered that synuclein can affect signal transmission between nerve cells long before disease symptoms arise.